GO:0003218 cardiac left ventricle formation: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003218 cardiac left ventricle formation describes the developmental process pertaining to the initial formation of a left cardiac ventricle from unspecified parts.
• The left ventricle is the systemic pump of the heart, and its formation is a morphogenetic process that establishes chamber identity, trabeculation, compaction, and coronary perfusion.
• Left ventricular structure and function are studied with structure-function analyses, perfusion physiology, and metabolic imaging.
• Altered left ventricular formation and maturation are linked to fetal growth restriction, cardiac hypertrophy, and heart failure.
• Comparative and translational models, including highland deer mice and growth-restricted fetuses, reveal metabolic and redox adaptations of the left ventricle.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes implicated in left ventricular formation.
Description
GO:0003218 cardiac left ventricle formation is a biological process term in the Gene Ontology that refers to the developmental process pertaining to the initial formation of a left cardiac ventricle from unspecified parts. The left ventricle is the chamber responsible for pumping oxygenated blood into the systemic circulation, and its formation requires coordinated specification, proliferation, trabeculation, and compaction of cardiac progenitor cells. Because the left ventricle performs the highest-pressure workload in the heart, its structural and functional maturation has direct physiological consequences for cardiac output and systemic perfusion. Researchers study left ventricular formation to understand congenital heart defects, fetal adaptation to growth restriction, and the transition from compensatory hypertrophy to heart failure. Experimental work in animal models has characterized left ventricular performance, perfusion, and metabolic state, providing a framework for interpreting developmental perturbations. The term is therefore central to developmental cardiology, cardiac physiology, and translational research on chamber-specific heart disease.
cardiac left ventricle formation At A Glance
| GO ID | GO:0003218 |
|---|---|
| GO term | cardiac left ventricle formation |
| Ontology | biological_process |
| Synonym | none |
| Definition | The developmental process pertaining to the initial formation of a left cardiac ventricle from unspecified parts. |
| Major function | Establishment of the left cardiac ventricle during heart development |
| Related anatomy | Left ventricle, systemic circulation pump |
| Related physiology | Cardiac output, left ventricular performance, coronary perfusion |
| Research relevance | Congenital heart defects, fetal growth restriction, cardiac hypertrophy, heart failure |
What Is GO:0003218?
In plain terms, GO:0003218 cardiac left ventricle formation is the developmental process by which the left cardiac ventricle is initially built from unspecified parts. It covers the early steps that establish the left ventricular chamber, rather than the later maturation or adult function of the chamber. The definition emphasizes initial formation from unspecified parts, meaning the process begins with progenitor or uncommitted cells that become organized into the left ventricular structure. This distinguishes it from terms describing right ventricular formation or later cardiac remodeling.
Why Is cardiac left ventricle formation Important in Cell Biology?
Cardiac left ventricle formation is important because the left ventricle is the primary pump for systemic circulation, and defects in its initial formation can lead to congenital heart disease and lifelong hemodynamic compromise. Understanding this process helps explain how chamber identity is established and how perturbations contribute to fetal growth restriction, hypertrophy, and heart failure. Because left ventricular performance is tightly linked to structure, studies of its formation inform physiological models of cardiac output and perfusion.
• The left ventricle generates the pressure needed for systemic perfusion, making its formation critical for survival.
• Defects in left ventricular formation are relevant to congenital heart disease and chamber-specific malformations.
• Fetal growth restriction is associated with altered left ventricular redox state and cardiac output.
• Left ventricular hypertrophy and heart failure involve aberrant glycosylation and metabolic remodeling.
• Comparative physiology in highland deer mice shows metabolic adaptations of left ventricular mitochondria.
• Structure-function analyses of the left ventricle provide quantitative frameworks for developmental studies.
• Right ventricular perfusion physiology offers contrast for understanding left ventricular perfusion requirements.
• Cardiac and general adiposity influence left ventricular morphology, linking metabolism to chamber structure.
• Left ventricular performance metrics are used to assess developmental and pathological changes.
• Synchronous assisted circulation studies provide historical context for supporting left ventricular function.
What Happens During cardiac left ventricle formation?
Specification of left ventricular identity
In simple terms: Early heart cells receive signals that tell them to become part of the left ventricle rather than another chamber.
The initial formation of the left cardiac ventricle from unspecified parts begins with the assignment of chamber identity within the developing heart tube. This step involves patterning cues that distinguish the left ventricular region from other cardiac segments, setting the stage for chamber-specific morphogenesis. The process is part of the broader developmental program that establishes a functional systemic pump.
Morphogenesis and chamber expansion
In simple terms: The left ventricular region grows and folds into a chamber shape.
After specification, the left ventricular primordium undergoes morphogenetic movements and expansion to form a recognizable chamber. This involves coordinated changes in cell shape, proliferation, and tissue folding that create the left ventricular cavity. Structure-function analyses of the left ventricle highlight how geometric and architectural features relate to its pumping role.
Trabeculation and compaction
In simple terms: The inner surface of the chamber first becomes spongy and then tightens into solid muscle.
During left ventricular formation, the myocardium initially forms trabeculae, which are finger-like projections that increase surface area and support nutrient exchange before coronary circulation is established. Subsequent compaction remodels these trabeculae into a compact myocardial wall. These steps are essential for building a chamber capable of high-pressure systemic output.
Establishment of perfusion and metabolic support
In simple terms: The growing left ventricle needs blood flow and energy to keep developing.
As the left ventricle forms, it requires perfusion and metabolic support. Studies of right ventricular perfusion provide comparative insight into how the heart supplies its own muscle, which is relevant to understanding left ventricular requirements. In fetal growth restriction, left ventricular redox ratio correlates with cardiac output, indicating that metabolic state is linked to pump performance during development.
Functional maturation of the left ventricle
In simple terms: The newly formed chamber becomes able to pump blood effectively.
The final stages of initial left ventricular formation involve functional maturation, including the development of contractile performance and the ability to generate systemic pressure. Left ventricular performance has been characterized in physiological studies, providing benchmarks for normal function. Mitochondrial function in the left ventricle also adapts to environmental conditions, as shown in highland deer mice.
Key Genes Involved in GO:0003218 cardiac left ventricle formation
The genes and proteins below are implicated in left ventricular biology, including formation, structure, function, and disease, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPPA | Cardiac natriuretic peptide involved in ventricular wall stress response | Marker of left ventricular hypertrophy and heart failure |
| NPPB | Cardiac natriuretic peptide involved in ventricular stress response | Marker of left ventricular dysfunction |
| MYH7 | Beta-myosin heavy chain, contractile protein of the ventricle | Left ventricular contractile function and hypertrophy |
| MYH6 | Alpha-myosin heavy chain, contractile protein | Left ventricular performance and chamber identity |
| TNNT2 | Cardiac troponin T, regulator of contraction | Left ventricular contractility and structure-function |
| ACTC1 | Cardiac actin, sarcomere component | Left ventricular morphogenesis and function |
| GATA4 | Transcription factor for cardiac development | Left ventricular formation and chamber specification |
| NKX2-5 | Homeobox transcription factor in heart development | Left ventricular patterning and formation |
| TBX5 | T-box transcription factor in cardiac development | Left ventricular chamber identity |
| HAND1 | Basic helix-loop-helix transcription factor | Left ventricular morphogenesis |
| HAND2 | Basic helix-loop-helix transcription factor | Cardiac chamber development |
| MEF2C | Transcription factor in cardiac muscle development | Left ventricular myocardial maturation |
| VEGFA | Vascular endothelial growth factor | Coronary perfusion and left ventricular development |
| ANGPT1 | Angiopoietin 1, vascular stabilization | Left ventricular perfusion and development |
| SOD2 | Mitochondrial superoxide dismutase | Left ventricular redox balance |
| UCP3 | Mitochondrial uncoupling protein | Left ventricular metabolic adaptation |
| PPARGC1A | PGC-1alpha, mitochondrial biogenesis regulator | Left ventricular mitochondrial function |
How Is cardiac left ventricle formation Regulated?
The formation and function of the left ventricle are regulated by developmental transcription factors, metabolic signaling, and redox balance. Fetal growth restriction alters the left ventricular redox ratio, which correlates with cardiac output, indicating that redox state participates in regulating pump performance. Mitochondrial function in the left ventricle is adjusted in response to environmental hypoxia, as demonstrated in highland deer mice. Cardiac hypertrophy and heart failure are associated with aberrant glycosylation in the left ventricle, suggesting that post-translational modifications contribute to regulation of ventricular remodeling. Perfusion physiology also regulates ventricular function by determining oxygen and substrate delivery.
cardiac left ventricle formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPPA | Left ventricular hypertrophy and heart failure | Knockout or overexpression in cardiomyocytes |
| NPPB | Left ventricular dysfunction | Point mutation to alter peptide processing |
| MYH7 | Hypertrophic cardiomyopathy | Knock-in of patient variants |
| GATA4 | Congenital heart defects | Knockout in cardiac progenitor cells |
| NKX2-5 | Congenital heart disease | Knockout and rescue models |
Fetal growth restriction and left ventricular dysfunction
Fetal growth restriction is associated with altered left ventricular redox ratio, which is positively correlated with cardiac output. This suggests that metabolic stress during development can influence left ventricular performance and may contribute to long-term cardiovascular risk.
Cardiac hypertrophy and heart failure
In cardiac hypertrophy and heart failure, aberrant glycosylation occurs in the left ventricle and plasma. These changes in glycosylation patterns may serve as markers of ventricular remodeling and disease progression.
Congenital heart defects affecting the left ventricle
Defects in the initial formation of the left cardiac ventricle can lead to congenital heart malformations. Understanding the developmental processes that build the left ventricle is essential for identifying the origins of such defects.
Metabolic and mitochondrial adaptations in the left ventricle
Left ventricular mitochondria adapt to environmental conditions such as high altitude, as shown in highland deer mice. These adaptations highlight how metabolic regulation of the left ventricle can be altered in response to physiological stress.
From cardiac left ventricle formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene cause left ventricular malformation? | Knockout in zebrafish or mouse |
| Does a specific point mutation alter left ventricular contractility? | Point-mutation knock-in in mouse |
| How does a human variant affect left ventricular development? | Knock-in of human variant in mouse |
| Where is a protein expressed during left ventricular formation? | Tagged knock-in with fluorescent reporter |
| Does overexpression of a gene drive left ventricular hypertrophy? | Cardiac-specific overexpression |
| What metabolic pathways support left ventricular formation? | Mitochondrial function assays in animal models |
How to Study the cardiac left ventricle formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Echocardiography | Left ventricular structure and function | Assessment of chamber dimensions and contractility |
| Redox ratio imaging | Metabolic redox state | Fetal growth restriction studies |
| Mitochondrial respirometry | Mitochondrial function | Comparative physiology of left ventricle |
| Glycosylation profiling | Post-translational modifications | Hypertrophy and heart failure biomarkers |
| Perfusion imaging | Myocardial blood flow | Ventricular perfusion physiology |
| Adiposity assessment | Cardiac and general adiposity | Prediction of left ventricular morphology |
| Performance testing | Left ventricular pump function | Physiological studies of cardiac output |
| Assisted circulation models | Synchronous support of left ventricle | Historical and translational circulatory support |
Structure-function analysis of the left ventricle
Structure-function analyses quantify the relationship between left ventricular geometry and pump performance. These methods provide baseline parameters for evaluating developmental perturbations.
Perfusion and metabolic imaging
Perfusion studies measure blood flow to the ventricular myocardium, which is critical for understanding how the left ventricle is supported during formation and in disease. Redox ratio imaging can assess metabolic state in the left ventricle.
Mitochondrial function assays
Mitochondrial function in the left ventricle can be measured to assess metabolic adaptations. Comparative studies in highland deer mice demonstrate how mitochondrial performance is tuned to environmental conditions.
Glycosylation profiling
Aberrant glycosylation in the left ventricle and plasma can be profiled to identify biomarkers of hypertrophy and heart failure. These methods reveal post-translational changes associated with ventricular remodeling.
How CRISPR Can Be Used to Study GO:0003218 cardiac left ventricle formation
Knockout
CRISPR knockout of genes implicated in left ventricular formation can reveal essential roles in chamber specification, trabeculation, and compaction. For example, knocking out GATA4 or NKX2-5 in cardiac progenitors can test their requirement for left ventricular development.
Point Mutation
Point mutations can model human variants associated with left ventricular disease. Introducing a specific mutation in MYH7, for instance, allows assessment of its effect on contractility and hypertrophy.
Knock-in
Knock-in of human disease variants or reporter tags enables precise tracking of gene expression and function during left ventricular formation. This approach is useful for studying congenital heart defects linked to transcription factor mutations.
Overexpression
Overexpression of genes such as NPPA or NPPB in the heart can drive left ventricular hypertrophy and heart failure phenotypes, providing models to study disease mechanisms and potential therapies.
How EDITGENE Supports cardiac left ventricle formation Research
Researchers studying cardiac left ventricle formation-related genes often need to determine whether a candidate gene is causally involved in chamber development, contractile function, or disease progression. EDITGENE provides CRISPR-based cell and animal models to test these hypotheses with precision.
Contact EDITGENE today to design your custom CRISPR model for cardiac left ventricle formation research.
Frequently Asked Questions About cardiac left ventricle formation
What is GO:0003218 cardiac left ventricle formation?
GO:0003218 is a Gene Ontology biological process term defined as the developmental process pertaining to the initial formation of a left cardiac ventricle from unspecified parts.
What genes are involved in cardiac left ventricle formation?
Genes such as GATA4, NKX2-5, TBX5, HAND1, and HAND2 are implicated in left ventricular development, along with contractile genes like MYH7 and TNNT2.
Why is the left ventricle important?
The left ventricle pumps oxygenated blood into the systemic circulation and generates the highest pressure in the heart.
How is left ventricular formation studied?
It is studied using structure-function analyses, perfusion imaging, mitochondrial function assays, and glycosylation profiling in animal models.
What diseases are linked to left ventricular formation?
Fetal growth restriction, cardiac hypertrophy, heart failure, and congenital heart defects are linked to left ventricular development and function.
What is the role of redox state in the left ventricle?
The redox ratio in the left ventricle of growth-restricted fetuses is positively correlated with cardiac output, indicating a link between metabolic state and pump performance.
How do mitochondria support the left ventricle?
Left ventricular mitochondria adapt to environmental conditions such as high altitude, as shown in highland deer mice.
What is aberrant glycosylation in the left ventricle?
Aberrant glycosylation in the left ventricle and plasma occurs in cardiac hypertrophy and heart failure and may serve as a disease marker.
Can CRISPR be used to study left ventricular formation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the causal role of genes in left ventricular development and disease.
What is the difference between left and right ventricular perfusion?
Right ventricular perfusion physiology differs from the left ventricle, and understanding both is important for cardiac function.
Conclusion
GO:0003218 cardiac left ventricle formation defines the developmental process that builds the left cardiac ventricle from unspecified parts. This process is fundamental to establishing a functional systemic pump, and its perturbation is linked to fetal growth restriction, hypertrophy, heart failure, and congenital heart defects. Research using physiological, metabolic, and CRISPR-based approaches continues to uncover the genes and pathways that regulate left ventricular formation and function.
References
- 1. Dimasi CG et al.. 2021. Redox ratio in the left ventricle of the growth restricted fetus is positively correlated with cardiac output.. J Biophotonics 14(12):e202100157 PMID: 34499415
- 2. Mahalingam S et al.. 2023. Function of left ventricle mitochondria in highland deer mice and lowland mice.. J Comp Physiol B 193(2):207-217 PMID: 36795175
- 3. Snelling EP et al.. 2016. A structure-function analysis of the left ventricle.. J Appl Physiol (1985) 121(4):900-909 PMID: 27586835
- 4. Nagai-Okatani C et al.. 2016. Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure.. PLoS One 11(6):e0150210 PMID: 27281159
- 5. Crystal GJ et al.. 2018. Right Ventricular Perfusion: Physiology and Clinical Implications.. Anesthesiology 128(1):202-218 PMID: 28984631
- 6. Iacobellis G et al.. 2006. Different "weight" of cardiac and general adiposity in predicting left ventricle morphology.. Obesity (Silver Spring) 14(10):1679-84 PMID: 17062795
- 7. Mitchell JH et al.. 1972. Performance of the left ventricle.. Am J Med 53(4):481-94 PMID: 4561894
- 8. Birtwell WC et al.. 1966. Synchronous assisted circulation.. Can Med Assoc J 95(13):652-64 PMID: 5922697
